ARCHIVE SEARCH
      -OR-  
 
  NEWS CHANNELS
Fitness News
Asthma Allergy News
 > Diabetes News
Women's Health News
Men's Health News

  MY NEWS
Personal Archive
My Account

  ABOUT THIS NEWSFEED
About Us
Advertise With Us
Feed Your Site
Contact Us


Site Map
RSS News Feed 

  Website development & hosting
   by Cyber Software Solutions

 
Diabetes With Obesity Ups Liver Transplant Morbidity
However, these concomitant risk factors do not appear to affect recipient survival

WEDNESDAY, Jan. 29, 2014 (HealthDay News) -- Morbidity is increased in the early postoperative phase following liver transplant for patients who have obesity with diabetes mellitus, according to research published online Jan. 7 in Liver Transplantation.

In an effort to assess the influence of pre-transplant risk variables on postoperative morbidity and survival, Anna J. Dare, M.B.Ch.B., of the University of Auckland in New Zealand, and colleagues analyzed data from a cohort of 202 consecutive patients receiving a liver transplant. Variables included coronary artery disease, diabetes mellitus, hypertension, and obesity.

The researchers found a high level of agreement (86 percent) between body mass index and percentage of body fat for the classification of patients as obese or non-obese. Independent factors that increased risk for a higher postoperative event rate included diabetes mellitus (counts ratio [CR], 1.4; P < 0.001) and obesity (CR, 1.03; P < 0.001). The strongest predictor of increased risk for higher postoperative event rate (CR, 1.75; P < 0.001) and longer hospital stay (5.81 days; P < 0.01) was obesity with concomitant diabetes mellitus. No effect on survival (30-day, one-year, or five-year) was observed for independent metabolic risk factors.

"Early post-liver transplantation morbidity is highest in patients with concomitant obesity and diabetes mellitus, though these factors do not appear to influence recipient survival," the authors write.

Abstract
Full Text (subscription or payment may be required)



Copyright © 2014 HealthDay. All rights reserved.


Back to Top Stories
  GOOGLE ADS